Insulet (PODD) Accumulated Expenses (2010 - 2026)
Insulet's (PODD) quarterly Accumulated Expenses came in at $602.0 million in Q2 2026, up 32.77% on a YoY basis from $453.4 million in Q2 2025, and up 15.99% quarter-over-quarter from $519.0 million in Q1 2026.
Analysis
Insulet (PODD) Accumulated Expenses (2010 - 2026) Analysis & Trends
Insulet (PODD) has reported Accumulated Expenses for 17 consecutive years, with $602.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Accumulated Expenses rose 32.77% year-over-year to $602.0 million; the trailing twelve-month figure through Jun 2026 stood at $602.0 million (up 32.77% YoY), and the FY2025 full-year result was $586.7 million, up 38.41% from the prior year.
- Accumulated Expenses climbed to $602.0 million in Q2 2026 per PODD's latest filing, from $519.0 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $602.0 million in Q2 2026 and bottomed at $135.8 million in Q1 2022.
- Historically, Accumulated Expenses has averaged $371.1 million across 5 years, with a median of $369.3 million in 2023.
- The sharpest annual moves came in 2023 and 2024: Accumulated Expenses jumped 94.11% in 2023, then advanced 13.43% in 2024.
- Over 5 years, Accumulated Expenses stood at $301.0 million in 2022, then climbed by 24.15% to $373.7 million in 2023, then climbed by 13.43% to $423.9 million in 2024, then soared by 38.41% to $586.7 million in 2025, then advanced by 2.61% to $602.0 million in 2026.
- According to Business Quant data, Accumulated Expenses over the past three periods registered $602.0 million, $519.0 million, and $586.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.76 Bn | 175.16 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn |
| 3 | Medtronic | 117.20 Bn | 108.39 Bn | 6.34 Bn |
| 4 | Stryker | 104.01 Bn | 100.53 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.80 Bn | 45.55 Bn | 1.35 Bn |
| 7 | Alcon | 33.03 Bn | 31.58 Bn | 1.68 Bn |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn |
| 10 | Insulet | 9.35 Bn | 8.82 Bn | 562.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 602.00 Mn |
| Mar 31, 2026 | 519.00 Mn |
| Dec 31, 2025 | 586.70 Mn |
| Sep 30, 2025 | 518.70 Mn |
| Jun 30, 2025 | 453.40 Mn |
| Mar 31, 2025 | 378.60 Mn |
| Dec 31, 2024 | 423.90 Mn |
| Sep 30, 2024 | 414.20 Mn |
| Jun 30, 2024 | 365.00 Mn |
| Mar 31, 2024 | 308.60 Mn |
| Dec 31, 2023 | 373.70 Mn |
| Sep 30, 2023 | 319.20 Mn |
| Jun 30, 2023 | 282.80 Mn |
| Mar 31, 2023 | 263.60 Mn |
| Dec 31, 2022 | 301.00 Mn |
| Sep 30, 2022 | 241.70 Mn |
| Jun 30, 2022 | 192.50 Mn |
| Mar 31, 2022 | 135.80 Mn |
| Dec 31, 2021 | 164.30 Mn |
| Sep 30, 2021 | 141.70 Mn |